Clinical Trial Update: Pembrolizumab and Pemetrexed for Progressive Chordoma [Phase 2]

View source ↗

Summary

Saint John's Cancer Institute is conducting a Phase 2 trial of pembrolizumab in combination with pemetrexed for progressive chordoma; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Saint John's Cancer Institute | Conditions: Chordomas, Chordoma | Phase 2 | Status: RECRUITING